Navigation Links
American Capital Receives $60 Million From The Sale Of Lifoam Holdings And Generates An 11% Return On Its Investment

BETHESDA, Md., Jan. 17, 2013 /PRNewswire/ -- American Capital, Ltd. (Nasdaq: ACAS) ("American Capital") announced today that its portfolio company Lifoam Holdings, Inc. ("Lifoam") was sold to Jarden Corporation ("Jarden") (NYSE: JAH) on December 31, 2012.  American Capital received $60 million in debt and equity proceeds and realized a gain of $14 million, subject to post-closing adjustments.  American Capital's compounded annual rate of return earned on its debt and equity securities over the life of its investment was 11%, including interest, dividends, capital gain and fees.  

"American Capital's investment in Lifoam produced an attractive return for our shareholders," said Brian Graff , American Capital Senior Vice President and Senior Managing Director.  "We continue to search for new investment opportunities in a variety of business sectors, either as the sole investor in a One Stop Buyout® or with a sponsor in support of a private equity buyout."

Lifoam is a manufacturer and distributor of expandable polystyrene ("EPS") and polyurethane ("PUR") products for consumer, healthcare and commercial applications.  Lifoam's products include foam picnic coolers, reusable ice and freeze packs and sophisticated protective and thermal packaging products. 

"As a leader in each of its consumer, healthcare and commercial products business segments, Lifoam has demonstrated consistent and strong earnings growth even throughout the recession," said Jim Gregory , American Capital Principal, Buyouts Group.  "American Capital has been fortunate to partner with an exceptional management team, which has driven Lifoam's growth and successful expansion into the highly attractive healthcare cold chain packaging market.  We believe that Lifoam is a great addition to Jarden's business and will benefit from being part of the Jarden family."

Since American Capital's 1997 IPO through the third quarter of 2012, the company has earned a 10% compounded annual return, including interest, dividends, fees and net gains, on over 340 realizations of senior debt, subordinated debt, equity and structured products investments, totaling $18 billion of committed capital.  American Capital earned a 27% compounded annual return on the exit of its equity investments, including dividends, fees and net gains.

For a chart showing a partial listing of American Capital's exited portfolio companies, please go to .  

American Capital is a publicly traded private equity firm and global asset manager.  American Capital, both directly and through its asset management business, originates, underwrites and manages investments in middle market private equity, leveraged finance, real estate and structured products.  American Capital manages $18.6 billion of assets, including assets on its balance sheet and fee earning assets under management by affiliated managers, with $118 billion of total assets under management (including levered assets).  From its eight offices in the U.S. and Europe, American Capital and its affiliate, European Capital, will consider investment opportunities from $10 million to $750 million.  For further information, please refer to

This press release contains forward-looking statements. The statements regarding expected results of American Capital are subject to various factors and uncertainties, including the uncertainties associated with the timing of transaction closings, changes in interest rates, availability of transactions, changes in regional, national or international economic conditions, or changes in the conditions of the industries in which American Capital has made investments.

Brian Graff , Senior Vice President and Senior Managing Director
Dustin Smith , Managing Director, Buyouts Group
Jim Gregory , Principal, Buyouts Group

SOURCE American Capital, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Earnings Forecast Stock Alerts: American International Group, Teva Pharmaceutical, CSX, Exxon Mobil, Lowes, and Seagate
2. Americans United for Life Celebrates Win for Illinois Conscience Rights in Case AUL Championed Since 2005
3. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. American Pacific to Release Financial Results and Hold Fiscal 2012 Year-End and Fourth Quarter Investor Teleconference
6. The American Council for Patient Liberty on medical marijuana vending machines
7. National Community Pharmacists Association and Purdue Pharma Urge Americans to Safeguard Rx Medicines This Holiday Season
8. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
9. Emerging Data on USL261 (Intranasal Midazolam) to Be Presented at the 66th Annual Meeting of the American Epilepsy Society
10. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
11. American Academy of Pain Medicine Safe Opioid Prescribing Course Proves Highly Effective
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015   Micell Technologies ... DESSOLVE I and II trials of its MiStent Sirolimus ... ® ) were presented at the 27th Annual ... San Francisco , October 11-15. TCT ... cardiovascular medicine. MiStent SES was designed to optimize vessel ...
(Date:10/13/2015)... -- Health Gorilla ( ) today announced the launch ... secure platform for clinical data and communications poised to change ... healthcare in the US. The launch follows the closing of ... of $4.4M raised to date, with Data Collective ... Harris Barton , Orfin Ventures and ...
(Date:10/13/2015)... 2015 China Jo-Jo Drugstores, Inc. ... "), a leading China-based retail, wholesale and online distributor ... online and retail pharmacies, announced preliminary half year fiscal ... pharmacy through , growing 438% year over ... China Jo-Jo,s online sales are ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... ... In an age where the cost of energy is rising, Susquehanna Health’s ... 2009. The Williamsport Regional Medical Center (WRMC) campus has grown 50 percent since 2010, ... , According to Facilities Management Administrative Director Dieter Reichmann, this is the result of ...
(Date:10/13/2015)... ... October 13, 2015 , ... A child without a healthy mouth is ... the leading remote invisible aligner system, has joined with Global Dental Relief ... For each aligner treatment plan purchased, SmileCareClub will donate one clinic visit to a ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... Scientists in ... tissue biopsy in 18 patients with or without mesothelioma. Surviving Mesothelioma has just posted ... , The doctors from PhenoPath Laboratories in Seattle and the University of British Columbia ...
(Date:10/13/2015)... Miami, FL (PRWEB) , ... October 13, 2015 , ... ... announces the Driveway Snow Blanket, a snow melting invention that helps people in clearing ... $17 billion and will continue to grow at 3.8% per year," says Scott Cooper, ...
(Date:10/13/2015)... ... October 13, 2015 , ... With Fall weather approaching and holiday travel season ... Facebook Hair Styler Contest. , Enter to win! , How to Enter:, 1. ... Favorite Hair Style? , 3. Follow us on Instagram @thebeautyplace , 4. Share ...
Breaking Medicine News(10 mins):